Galzin (zinc acetate) is an oral medication taken as capsules. Strict adherence to the dosing schedule and administration instructions is crucial for its effectiveness in managing Wilson disease.
- Formulation: Galzin is available in capsules containing 25 mg or 50 mg of elemental zinc (as zinc acetate).
- Administration Method: Take the capsules by mouth.
- Swallow Whole: Swallow the capsule whole with water. Do not crush, chew, break, or open the capsule.
- Empty Stomach: Galzin must be taken on an empty stomach. This means taking it at least 1 hour before or 2 to 3 hours after meals. This is vital because food and certain beverages can significantly reduce zinc absorption.
- If zinc acetate causes stomach upset, especially with the morning dose, your doctor might advise taking that dose between breakfast and lunch, ensuring the required fasting period around it.
- Dosage Frequency: Galzin is typically taken three times daily.
- Consistency: Take your doses at the same times each day to maintain consistent levels of zinc in your body.
- Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.
- Long-Term Therapy: Galzin is a long-term treatment. Do not stop taking it without consulting your doctor, as this can lead to a re-accumulation of copper and worsening of Wilson disease.
- Monitoring: Regular lab tests (e.g., 24-hour urine copper levels, liver function tests, zinc levels) are essential to monitor treatment effectiveness and adjust the dose as needed.
Galzin’s mechanism of action is distinct from copper-chelating agents and is centered around the physiological role of zinc in copper metabolism. In Wilson disease, the genetic defect prevents the proper removal of excess copper.
Galzin works by:
- Induction of Metallothionein: When zinc acetate is ingested, it leads to an increased production of a protein called metallothionein within the cells lining the intestines (enterocytes).
- Copper Binding: Metallothionein has a very high affinity for binding heavy metals, including copper. When present in sufficient quantities, it binds copper in the intestinal cells.
- Blocking Absorption: The copper-metallothionein complex is stable and prevents copper from being absorbed into the bloodstream. Instead, the copper-bound metallothionein remains within the intestinal cells.
- Fecal Excretion: As intestinal cells naturally shed and are replaced, the metallothionein-bound copper is shed along with them and subsequently excreted in the feces.
This process effectively acts as a “blockade” against new copper absorption from the diet, thus preventing its accumulation and promoting the depletion of existing excess copper stores in the body over time. Zinc therapy is particularly advantageous for its good safety profile for long-term use.
While generally well-tolerated for long-term use, Galzin (zinc acetate) can cause side effects. Most common ones are gastrointestinal.
Common side effects (often mild and manageable):
- Upset stomach: Nausea, vomiting, stomach cramps, abdominal pain. Taking the medication precisely on an empty stomach as directed may help, or if severe, adjusting the timing of the morning dose (e.g., between breakfast and lunch) might be recommended by your doctor.
- Diarrhea.
- Metallic taste in mouth (usually diminishes with continued use).
- Elevations of serum alkaline phosphatase, amylase, and lipase: These suggest pancreatic irritation, but usually return to high normal within the first one or two years of therapy.
More serious, but less common, side effects that require immediate medical attention:
- Copper Deficiency: Long-term use of high doses of zinc can lead to severe copper deficiency due to its mechanism of blocking copper absorption. Symptoms can include anemia, neutropenia (low white blood cell count), leukopenia, pancytopenia, thrombocytopenia, and myeloneuropathy (nerve damage leading to weakness or numbness). Regular monitoring of copper levels is crucial to prevent this.
- Gastric Ulcer: Post-marketing reports have indicated cases of gastric ulcers with long-term use, sometimes leading to complications like perforation. Symptoms include severe stomach pain, black or tarry stools, or vomiting blood.
- Neurological Deterioration: In symptomatic patients, especially when zinc is used as initial monotherapy without prior chelation (which is generally not recommended), neurological symptoms may worsen temporarily as copper stores are mobilized.
- Serious Allergic Reaction: Although rare, signs of a severe allergic reaction can include rash, hives, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or trouble breathing.
Report any unusual, severe, or persistent side effects to your doctor immediately.
Due to the specific nature of Wilson disease and Galzin’s action, important warnings and precautions must be observed:
- Not for Initial Symptomatic Treatment: Galzin (zinc acetate) is generally not recommended as the initial therapy for symptomatic patients with Wilson disease. This is because zinc’s action of inducing metallothionein takes time (weeks to months) to become fully effective in blocking copper uptake. Symptomatic patients should typically be treated initially with a chelating agent to rapidly remove excess copper and stabilize their condition. Once stable, Galzin can be used for maintenance.
- Risk of Neurological Deterioration: During initial therapy for symptomatic patients (if zinc is used, or during the transition from chelators), neurological deterioration can occur as copper stores are mobilized. Close clinical monitoring is essential.
- Copper Deficiency: Long-term use carries a risk of inducing severe copper deficiency. Regular monitoring of 24-hour urinary copper, non-ceruloplasmin bound copper, and complete blood counts (CBC) is critical to detect and manage this complication. Zinc treatment may need to be interrupted if copper deficiency develops.
- Gastric Ulcers: Patients should be monitored for signs and symptoms of gastric ulcers, especially with long-term use. If ulcers occur, Galzin treatment may need to be discontinued.
- Monitoring Patients: Lifelong monitoring is essential. This includes regular assessment of clinical symptoms (especially neuropsychiatric status, including speech), liver function tests, and copper excretion parameters (e.g., 24-hour urinary copper).
- Adherence is Crucial: Strict adherence to the prescribed dosing regimen and dietary restrictions (avoiding high-copper foods, and taking zinc on an empty stomach) is vital for optimal control of copper metabolism in Wilson disease.
- Pregnancy and Lactation:
- Pregnancy: While zinc is considered safer than chelators during pregnancy for Wilson disease, its use still requires careful monitoring. The dose may be adjusted during pregnancy.
- Lactation: Zinc passes into breast milk. Breastfeeding while taking Galzin is generally not recommended due to the potential for inducing copper deficiency in the nursing infant. Discuss this with your doctor.
- Children: The safety and effectiveness in children younger than 10 years require careful consideration, and dosage should be guided by a specialist.
Galzin (zinc acetate) can interact with several other medications, primarily by affecting their absorption. This is because zinc ions can chelate (bind) to other molecules in the gastrointestinal tract, making them less absorbable. It’s crucial to inform your doctor or pharmacist about all medications you are currently taking.
Key interactions include:
- Tetracycline Antibiotics (e.g., doxycycline, minocycline): Zinc can bind to tetracyclines, significantly reducing the absorption and effectiveness of both the antibiotic and the zinc. It is generally recommended to take zinc acetate at least 2-3 hours apart from tetracycline antibiotics.
- Quinolone Antibiotics (e.g., ciprofloxacin, levofloxacin): Similar to tetracyclines, zinc can interfere with the absorption of quinolone antibiotics. These should also be taken at least 2-3 hours apart from Galzin.
- Bisphosphonates (e.g., alendronate): Zinc can decrease the absorption of bisphosphonates (used for osteoporosis). Separate the administration of these medications by at least 30 minutes to 2 hours, or as advised by your doctor.
- Deferasirox: Zinc acetate can decrease the absorption of deferasirox (another copper chelator), potentially reducing its efficacy. This combination requires careful monitoring by a specialist.
- Raltegravir and Halofantrine: Zinc acetate can decrease the absorption of these drugs as well.
- Carbamazepine and Ceftibuten: Moderate interaction where zinc acetate can decrease their absorption.
- Foods and Beverages: Foods (especially those high in fiber, dairy, coffee, bread, bran, boiled eggs) can significantly decrease the absorption of zinc. Therefore, Galzin must be taken on an empty stomach.
Always consult your doctor or pharmacist for a personalized dosing schedule if you are taking any of these medications concurrently with Galzin.
The dosage of Galzin (zinc acetate) is individualized based on the patient’s age, weight, clinical status, and response to treatment, and is expressed as elemental zinc.
- Adults (Maintenance Therapy or Asymptomatic Patients):
- Typical dose: 50 mg of elemental zinc three times daily.
- Some patients may be started on 25 mg three times daily, especially if compliance is a concern. The dose can be increased to 50 mg three times daily if monitoring indicates inadequate control of copper.
- Children (aged 10 years or older) and Adolescents:
- Typically 25 mg of elemental zinc three times daily.
- The dose can be increased to 50 mg three times daily if monitoring indicates inadequate control.
- Children (aged 5 years and under 50 kg):
- According to AASLD (American Association for the Study of Liver Diseases) guidelines: 25 mg orally three times daily.
- Pregnant Women:
- Typically 25 mg of elemental zinc three times daily. The dose may be increased to 50 mg three times daily if needed, based on monitoring.
- Administration: Always take Galzin on an empty stomach, at least 1 hour before or 2-3 hours after meals. Swallow capsules whole.
- Monitoring: Dosage adjustments are made based on 24-hour urinary copper levels, non-ceruloplasmin bound copper (NCC), clinical signs and symptoms, and liver function tests. The goal is to achieve a negative copper balance and prevent copper accumulation while avoiding zinc-induced copper deficiency.
Galzin (zinc acetate) is a prescription-only medication (POM). It is not available over-the-counter in Pakistan or in most other countries with regulated healthcare systems. Its status as a prescription drug is due to several critical factors:
- Complex Disease Management: Wilson disease is a severe and rare genetic disorder requiring precise diagnosis and lifelong management by specialists.
- Specialist Oversight: Treatment initiation and ongoing care with Galzin must be overseen by a medical doctor experienced in the diagnosis and treatment of Wilson disease (e.g., a hepatologist, neurologist, or geneticist).
- Individualized Dosing and Monitoring: The dosage needs to be carefully tailored to each patient, and rigorous monitoring through specialized lab tests (e.g., 24-hour urine copper, serum zinc, liver function) is essential to ensure efficacy and prevent severe complications like copper deficiency.
- Potential for Serious Side Effects: Although generally safe, the risk of inducing copper deficiency or gastric ulcers necessitates close medical supervision.
- Drug Interactions: The potential for interactions with various other medications requires a healthcare professional to manage the patient’s overall drug regimen.
- Long-Term Commitment: It is a lifelong therapy, requiring consistent patient adherence and ongoing medical follow-up.
Therefore, a licensed medical doctor, specializing in the management of Wilson disease, must prescribe Galzin.
